CYP2S1
Cytochrome P450 2S1
Also known as: CP2S1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96SQ9
- Gene
- CYP2S1
- Ensembl
- ENSG00000167600
- Chromosome
- 19
- Canonical length
- 504 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Endoplasmic reticulum
OverviewNCBI Gene
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. In rodents, the homologous protein has been shown to metabolize certain carcinogens; however, the specific function of the human protein has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
504 residues, UniProt reviewed canonical sequence.
>Q96SQ9|CYP2S1
1 MEATGTWALL LALALLLLLT LALSGTRARG HLPPGPTPLP LLGNLLQLRP GALYSGLMRL
61 SKKYGPVFTI YLGPWRPVVV LVGQEAVREA LGGQAEEFSG RGTVAMLEGT FDGHGVFFSN
121 GERWRQLRKF TMLALRDLGM GKREGEELIQ AEARCLVETF QGTEGRPFDP SLLLAQATSN
181 VVCSLLFGLR FSYEDKEFQA VVRAAGGTLL GVSSQGGQTY EMFSWFLRPL PGPHKQLLHH
241 VSTLAAFTVR QVQQHQGNLD ASGPARDLVD AFLLKMAQEE QNPGTEFTNK NMLMTVIYLL
301 FAGTMTVSTT VGYTLLLLMK YPHVQKWVRE ELNRELGAGQ APSLGDRTRL PYTDAVLHEA
361 QRLLALVPMG IPRTLMRTTR FRGYTLPQGT EVFPLLGSIL HDPNIFKHPE EFNPDRFLDA
421 DGRFRKHEAF LPFSLGKRVC LGEGLAKAEL FLFFTTILQA FSLESPCPPD TLSLKPTVSG
481 LFNIPPAFQL QVRPTDLHST TQTRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYP2S1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 114 nTPM
Expression across tissuesHPA
Tissue
- stomach: 114 nTPM
- duodenum: 95 nTPM
- small intestine: 62 nTPM
- colon: 25 nTPM
- rectum: 17 nTPM
- esophagus: 15 nTPM
Single-cell type
- foveolar cells: 232 nCPM
- cdc: 61 nCPM
- enterocytes: 58 nCPM
- respiratory basal cells: 46 nCPM
- goblet cells: 40 nCPM
- cytotrophoblasts: 31 nCPM
Immune cell
- myeloid DC: 85 nTPM
- classical monocyte: 25 nTPM
- total PBMC: 11 nTPM
- intermediate monocyte: 5.9 nTPM
- non-classical monocyte: 3.8 nTPM
- plasmacytoid DC: 3.2 nTPM
Brain region
- midbrain: 21 nTPM
- pons: 12 nTPM
- medulla oblongata: 8.7 nTPM
- hypothalamus: 8 nTPM
- thalamus: 6.9 nTPM
- cerebellum: 5.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.89
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytochrome metabolic process
- epoxygenase P450 pathway
- icosanoid metabolic process
- prostaglandin metabolic process
- retinoic acid metabolic process
- xenobiotic metabolic process
Molecular functions
- 12-hydroxyheptadecatrienoic acid synthase activity
- arachidonate epoxygenase activity
- heme binding
- hydro-lyase activity
- hydroperoxy icosatetraenoate dehydratase activity
- iron ion binding
- monooxygenase activity
- oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
- retinoic acid 4-hydroxylase activity
- thromboxane-A synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYP2S1 as an antibody target. Whether an autoantibody or antibody against CYP2S1 could matter depends on whether native CYP2S1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYP2S1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CYP2S1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...